Resolv ER

N/A

Report date: 2022/03/03 18:01:47
NME

Base Information

Drug NameResolv ER
Drug Alias NameResolv ER
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVitreomacular Adhesion
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKato Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesKato Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsVitreomacular Adhesion
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A